Journal list menu
Export Citations
Download PDFs
Cover Image
Issue Information
Hepatology Highlights
Comments from the Editors
Free Access
free
Professional Use of Social Media by Hepatology Providers
- Pages: 2089-2091
- First Published: 20 March 2021
Editorials
Free Access
free
Fructose Promotion of Intestinal and Liver Injury: A Sugar by Any Other Name That Isn't So Sweet
- Pages: 2092-2094
- First Published: 05 July 2019
Free Access
free
Noninvasive Tests to Phenotype Nonalcoholic Fatty Liver Disease: Sequence and Consequences of Arranging the Tools in the Tool Box
- Pages: 2095-2098
- First Published: 05 February 2021
Rapid Communication
Free Access
free
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study
- Pages: 2099-2109
- First Published: 13 March 2021
Original Articles
Viral Hepatitis
Free Access
free
Prospective Multicenter Study of Early Antiviral Therapy in Liver and Kidney Transplant Recipients of HCV-Viremic Donors
- Pages: 2110-2123
- First Published: 14 September 2020
Free Access
free
Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy
- Pages: 2124-2140
- First Published: 16 September 2020
Free Access
free
Diagnosis of Chronic Hepatitis B Pericomplication: Risk factors and Trends Over Time
- Pages: 2141-2154
- First Published: 15 September 2020
Free Access
free
Comparison of Long-Term Clinical Outcomes Between Spontaneous and Therapy-Induced HBsAg Seroclearance
- Pages: 2155-2166
- First Published: 01 November 2020
Free Access
free
HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy
- Pages: 2167-2179
- First Published: 06 November 2020
Steatohepatitis/Metabolic Liver Disease
Free Access
free
Fructose Promotes Leaky Gut, Endotoxemia, and Liver Fibrosis Through Ethanol-Inducible Cytochrome P450-2E1–Mediated Oxidative and Nitrative Stress
- Pages: 2180-2195
- First Published: 08 April 2019
Free Access
free
Transient Versus Two-Dimensional Shear-Wave Elastography in a Multistep Strategy to Detect Advanced Fibrosis in NAFLD
- Pages: 2196-2205
- First Published: 24 November 2020
Free Access
free
Activating Adenosine Monophosphate–Activated Protein Kinase Mediates Fibroblast Growth Factor 1 Protection From Nonalcoholic Fatty Liver Disease in Mice
- Pages: 2206-2222
- First Published: 23 September 2020
Open Access
oa
Promoterless, Nuclease-Free Genome Editing Confers a Growth Advantage for Corrected Hepatocytes in Mice With Methylmalonic Acidemia
- Pages: 2223-2237
- First Published: 25 September 2020
Free Access
free
ABIDE: An Accurate Predictive Model of Liver Decompensation in Patients With Nonalcoholic Fatty Liver-Related Cirrhosis
- Pages: 2238-2250
- First Published: 25 September 2020
Free Access
free
Hepatocyte Nuclear Factor 4α Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice)
- Pages: 2251-2265
- First Published: 23 October 2020
Free Access
free
Association of Metabolic Risk Factors With Risks of Cancer and All-Cause Mortality in Patients With Chronic Hepatitis B
- Pages: 2266-2277
- First Published: 02 November 2020
Hepatobiliary Malignancies
Free Access
free
HepatoScore-14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk
- Pages: 2278-2292
- First Published: 15 September 2020
Open Access
oa
Epigenome-Wide Analysis of Methylation Changes in the Sequence of Gallstone Disease, Dysplasia, and Gallbladder Cancer
- Pages: 2293-2310
- First Published: 05 October 2020
Open Access
oa
Liver Metastases of Intrahepatic Cholangiocarcinoma: Implications for an Updated Staging System
- Pages: 2311-2325
- First Published: 18 October 2020
Open Access
oa
Lysyl Oxidase-Like 4 Fosters an Immunosuppressive Microenvironment During Hepatocarcinogenesis
- Pages: 2326-2341
- First Published: 17 October 2020
Free Access
free
Genomic Analysis of Vascular Invasion in HCC Reveals Molecular Drivers and Predictive Biomarkers
- Pages: 2342-2360
- First Published: 03 November 2020
Free Access
free
Ras Homolog Family Member F, Filopodia Associated Promotes Hepatocellular Carcinoma Metastasis by Altering the Metabolic Status of Cancer Cells Through RAB3D
- Pages: 2361-2379
- First Published: 18 November 2020
Free Access
free
Dual Targeting of G9a and DNA Methyltransferase-1 for the Treatment of Experimental Cholangiocarcinoma
- Pages: 2380-2396
- First Published: 22 November 2020
Autoimmune, Cholestatic and Biliary Disease
Free Access
free
Mast Cells Induce Ductular Reaction Mimicking Liver Injury in Mice Through Mast Cell–Derived Transforming Growth Factor Beta 1 Signaling
- Pages: 2397-2410
- First Published: 06 August 2020
Free Access
free
The Apelin–Apelin Receptor Axis Triggers Cholangiocyte Proliferation and Liver Fibrosis During Mouse Models of Cholestasis
- Pages: 2411-2428
- First Published: 07 September 2020
Liver Failure/Cirrhosis/Portal Hypertension
Free Access
free
Appropriate and Potentially Inappropriate Medication Use in Decompensated Cirrhosis
- Pages: 2429-2440
- First Published: 10 September 2020
Open Access
oa
Analysis of Survival Benefits of Living Versus Deceased Donor Liver Transplant in High Model for End-Stage Liver Disease and Hepatorenal Syndrome
- Pages: 2441-2454
- First Published: 02 October 2020
Open Access
oa
Contrast-Enhanced Ultrasonography–Based Hepatic Perfusion for Early Prediction of Prognosis in Acute Liver Failure
- Pages: 2455-2467
- First Published: 05 November 2020
Free Access
free
Endothelial p300 Promotes Portal Hypertension and Hepatic Fibrosis Through C-C Motif Chemokine Ligand 2–Mediated Angiocrine Signaling
- Pages: 2468-2483
- First Published: 07 November 2020
Liver Injury/Regeneration
Free Access
free
HLA-B*35:01 and Green Tea–Induced Liver Injury
- Pages: 2484-2493
- First Published: 05 September 2020
Free Access
free
Exercise Training Decreases Hepatic Injury and Metastases Through Changes in Immune Response to Liver Ischemia/Reperfusion in Mice
- Pages: 2494-2509
- First Published: 14 September 2020
Open Access
oa
Hepatocyte Mitogen-Activated Protein Kinase Kinase 7 Contributes to Restoration of the Liver Parenchyma Following Injury in Mice
- Pages: 2510-2526
- First Published: 23 September 2020
Liver Biology/Pathobiology
Open Access
oa
Hexa Histidine–Tagged Recombinant Human Cytoglobin Deactivates Hepatic Stellate Cells and Inhibits Liver Fibrosis by Scavenging Reactive Oxygen Species
- Pages: 2527-2545
- First Published: 11 February 2021
Reviews
Free Access
free
Application of Artificial Intelligence for the Diagnosis and Treatment of Liver Diseases
- Pages: 2546-2563
- First Published: 23 October 2020
Free Access
free
Cardiac Risk Assessment in Liver Transplant Candidates: Current Controversies and Future Directions
- Pages: 2564-2576
- First Published: 20 November 2020
Open Access
oa
Targeting the Four Pillars of Enterohepatic Bile Salt Cycling; Lessons From Genetics and Pharmacology
- Pages: 2577-2585
- First Published: 22 November 2020
Hepatology Elsewhere
Free Access
free
A Call for Randomization in Clinical Trials of Liver Machine Perfusion Preservation
- Pages: 2586-2591
- First Published: 17 December 2020
Free Access
free
Immune Checkpoint Inhibitors in Combinations for Hepatocellular Carcinoma
- Pages: 2591-2593
- First Published: 12 January 2021
Clinical Observations in Hepatology
Free Access
free
Long-Term Observation of Cyclosporine as Second-Line Therapy in Adults for Severe Acute Autoimmune Hepatitis
- Pages: 2594-2597
- First Published: 17 October 2020
Free Access
free
Improved Markers of Cholestatic Liver Injury in Patients With Primary Biliary Cholangitis Treated With Obeticholic Acid and Bezafibrate
- Pages: 2598-2600
- First Published: 03 November 2020
Free Access
free
Safety and Efficacy of Budesonide During Pregnancy in Women With Autoimmune Hepatitis
- Pages: 2601-2606
- First Published: 14 November 2020
Correspondence
Free Access
free
Letter to the Editor: The Limited Functions and Mechanisms of CircASAP1 as a Sponge of Onco-microRNAs
- Page: 2610
- First Published: 26 October 2020
Free Access
free
Letter to the Editor: Using Circulating Biomarkers to Stage HCC: Pitfalls and Limitations
- Page: 2611
- First Published: 10 November 2020
Free Access
free
Letter to the Editor: Comment on “HepatoScore-14: Measures of Biological Heterogeneity Significantly Improve Prediction of Hepatocellular Carcinoma Risk”
- Pages: 2613-2614
- First Published: 10 November 2020
Free Access
free
Letter to the Editor: Post–Liver Transplantation Sinusoidal Obstruction Syndrome and Immunosuppressive Drugs: Causality of Mycophenolate Mofetil or Tacrolimus?
- Pages: 2615-2616
- First Published: 13 November 2020
Free Access
free
Letter to the Editor: Should Growth Pattern of Hepatocellular Carcinoma Be Constant and Homogenous?
- Pages: 2617-2618
- First Published: 18 November 2020
Free Access
free
Letter to the Editor: Living Donor Liver Transplantation or Deceased Donor Liver Transplantation in High Model for End-Stage Liver Disease Score—Which Is Better?
- Pages: 2619-2620
- First Published: 23 November 2020